DeFloria LLC Commences Phase 1 Clinical Program for Full Spectrum Hemp Botanical Drug
DENVER – Charlotte’s Web Holdings Inc., A market leader in full-spectrum hemp extract wellness products, and AJNA BioSciences PBC, a botanical drug development company focused on mental health and neurological disorders, announced today that DeFloria LLC commenced its First-in-Human Phase 1 clinical trial for AJA001, a full-spectrum botanical drug. Dr. Orrin Devinsky Ph.D., the Chief Medical Advisor at AJNA Biosciences stated, “Our phase 1 entrance marks a critical milestone in AJA001’s clinical timeline and advances a full-spectrum cannabinoid formulation into rigorous clinical trials that are essential to advance medical science. We are proud of our team’s hard work reach this point, and I am excited to help develop the Phase 2 program for this new drug.” AJA001’s initial research is dedicated to the examination of the safety, tolerability, pharmacokinetics, and pharmacodynamics in fasted and fed healthy participants of a full spectrum hemp oil extracted from one of ...